Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7147712

COc1cccc(CN)c1OC.NCc1cccc(C2CCN(C(=O)O)CC2)c1.O=C(O)C(F)(F)F

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TPSAB1 Q15661 19/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4403918 0.88 TPSAB1 (0.51) TPSAB1
SCHEMBL4405378 0.79 TPSAB1 (0.58) TPSAB1
Trifluoroacetic Acid SCHEMBL4412975 0.77 TPSAB1 (0.60) TPSAB1
Trifluoroacetic Acid SCHEMBL4397995 0.76 TPSAB1 (0.69) TPSAB1
Trifluoroacetic Acid SCHEMBL4407730 0.75 TPSAB1 (0.65) TPSAB1
Trifluoroacetic Acid SCHEMBL4410596 0.72 TPSAB1 (0.65) TPSAB1
Trifluoroacetic Acid SCHEMBL4399080 0.72 TPSAB1 (0.62) TPSAB1
SCHEMBL15861686 0.72 KDM4E (0.56) TPSAB1
SCHEMBL15861685 0.72 KDM4E (0.56) TPSAB1
Trifluoroacetic Acid SCHEMBL4398697 0.72 TPSAB1 (0.61) TPSAB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296972-A1 ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRYPTASE INHIBITORS Aventis Pharmaceuticals Inc. (US) 2003-04-02 EP disclosed
WO-2001090101-A1 ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRYPTASE INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2001-11-29 WO disclosed